Ceapro Closes a Loan Agreement with Symrise AG
20 12월 2013 - 9:00PM
Marketwired
Ceapro Closes a Loan Agreement with Symrise AG
EDMONTON, ALBERTA--(Marketwired - Dec 20, 2013) - Ceapro Inc.
(TSX-VENTURE:CZO) ("Ceapro" or "the Company") is very pleased to
announce the signing of a Loan Agreement with its major partner,
Symrise, a German-based multinational company.
"This significant financial support from Symrise fully provides
Ceapro with the required capital to complete the construction and
implementation of the state of the art facility in Edmonton," said
Gilles Gagnon, President and CEO of Ceapro. "This loan from Symrise
follows the signing earlier this year of a long-term Distribution
Agreement between Symrise and Ceapro. We are again delighted and
honoured with this recognition and vote of confidence from such a
highly respected international player in our industry," he
added.
"This Agreement is further evidence of the long-term partnership
between Ceapro and Symrise and we look forward to the next steps in
joining forces and competencies for the development of new products
and new markets," said Dr. Klaus Stanzl, President and CEO, Life
Essentials Division, Symrise Ag.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company.
Primary business activities relate to the development and
commercialization of active ingredients for personal care and
cosmetic industries using proprietary technology and natural,
renewable resources. To learn more about Ceapro, visit
www.ceapro.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Branko JankovicVice President and CFOCeapro Inc.Telephone
(Edmonton): 780.917.8376Email: bjankovic@ceapro.com
Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Ceapro (TSXV:CZO)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024